Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial

Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial

Introduction Biannual mass azithromycin distribution to children aged 1–59 months has been shown to reduce all-cause mortality. Children under 28 days of age were not treated in studies evaluating mass azithromycin distribution for child mortality due to concerns related to infantile hypertrophic py...

Full description

Saved in:
Bibliographic Details
Main Authors: Till Bärnighausen, Catherine E Oldenburg, Thomas M Lietman, Thuy Doan, Wafaie Fawzi, Ali Sie, Lucienne Ouermi, Pascal Zabre, Elodie Lebas, Mamadou Bountogo, Eric Nebie, Mamadou Ouattara, Boubacar Coulibaly, Cheik Bagagnan, Jessica Brogdon, William W Godwin, Ying Lin, Travis Porco, Alphonse Zakane, Guillaume Compaoré, Valentin Boudo, Aristide Ouedraogo, Ouedraogo Andiyam Thierry, A.M. Napon, Z. Nikièma, Allen Hightower, Amza Abdou, Miriam Laufer, Jacqueline Glover, Catherine Cook, William W. Godwin, Jeremy D. Keenan, Thomas M. Lietman, Kieran S. O’Brien, Catherine E. Oldenburg, Travis C. Porco
Format: Article
Language:English
Published: BMJ Publishing Group 2019-09-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/9/9/e031162.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://bmjopen.bmj.com/content/9/9/e031162.full

Similar Items